3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Turcot syndrome
1
Pancreatic Neoplasms
1
Neoplasms
1
Colorectal Neoplasms
1
COVID-19
1
Interventions
Specimen Handling
3
COVID-19 Vaccines
3
Blood Specimen Collection
3
Surveys and Questionnaires
2
Standard of Care
2
Practice Guidelines as Topic
2
COH04S1 COVID-19 vaccine
2
2019-nCoV Vaccine mRNA-1273
2
sotrovimab
1
ciclesonide
1
Therapeutics
1
Telemedicine
1
Sodium Chloride
1
Patient Reported Outcome Measures
1
Observation
1
Nutritional Status
1
Niclosamide
1
NVX-CoV2373 adjuvated lipid nanoparticle
1
IMM-101
1
Exercise Therapy
1
Exercise
1
Educational Status
1
Diagnostic Tests, Routine
1
Data Collection
1
CVnCoV COVID-19 vaccine
1
BNT162 Vaccine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
COVID-19
×
IMM-101
×
1 year
×
Clear all
NCT04442048
2025-12-30
COV-IMMUNO
Canadian Cancer Trials Group
Phase 3
Completed
195 enrolled